An exciting milestone for the OmiCrohn study!
The 100th participant has been enrolled in the study. And the number is already up to 104 participants, meaning we have now reached 27.5% of our target of 378 participants.
In all participating countries – the United Kingdom, Belgium, the Netherlands, Italy, Hungary and Slovenia – teams are working hard to enrol more people with Crohn’s disease.
FAQ, study summary and goals
- Do your patients have questions about the study?
The most important questions and answers can be found in the FAQ here. - You can also read a summary of the OmiCrohn study and a summary of the METHYLOMIC project.